Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Hematological Oncology|August 29, 2000
Prognostic models for diffuse large B-cell lymphomaA Conconi, E Zucca, E Roggero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
Clinical significance of bcl-2 (MBR)/JH rearrangement in the peripheral blood of patients with diffuse large B-cell lymphomasE Zucca, F Bertoni, G Bosshard, et al.
Deutsche Medizinische Wochenschrift (1946)|September 17, 1993
[Castleman's disease]M Genoni, D De Lorenzi, M Bogen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
High incidence of other neoplasms in patients with low-grade gastric MALT lymphomaE Zucca, G Pinotti, E Roggero, et al.
Research Communications in Chemical Pathology and Pharmacology|June 1, 1987
Cerebral distribution of beta-lipotropin and beta-endorphin in infantile progressive spinal muscular atrophy of Werdnig and Hoffman diseaseA Pasi, P Mehraein, E Pedrinis, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 7, 2002
[Rupture of a sinus of Valsalva aneurysm in the left atrium]E Bouvier, J M Porte, T Laperche, et al.
Leukemia & Lymphoma|December 28, 1999
Primary mediastinal large B-cell lymphoma: the need for prospective controlled clinical trialsS Bieri, E Roggero, E Zucca, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|March 10, 2000
[Quality control in patient education. Results of a patient survey about the patient education protocol of the Swiss Society of Surgery in 6 Swiss hospitals]W Kessler, K Faisst, M Kessler, et al.
International Journal of Colorectal Disease|August 9, 2008
Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trialU Laffer, U Metzger, P Aeberhard, et al.
Leukemia & Lymphoma|October 8, 1999
Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trialsS Bieri, E Roggero, E Zucca, et al.
Pageof 14